arrow
H

Hong Zhao

The Second Hospital of Lanzhou University教授
H指数:75
被引数:3.3万

个人简介

Hong Zhao is a master's tutor and a professor at the School of Computer Science at Minnan Normal University. She has received a PhD degree in Software Engineering, from Tianjin University. She is a provincial-level high-level talent in Fujian, a member of the granular computing and knowledge discovery professional committee of the Chinese Artificial Intelligence Society, an executive director of the Fujian Artificial Intelligence Society, a director of the Fujian Computer Society, and an editorial board member at Engineering Applications of Artificial Intelligence (EAAI, Elsevier Q1). She researches hierarchical modeling and few-shot learning in a big data environment. She has presided over or completed more than ten projects, including the National Natural Science Foundation of China, the National Natural Science Foundation youth projects, the Natural Science Foundation of Fujian Province, and the Fujian Provincial Department of Education key projects. She has published more than 80 academic papers in journals and academic conferences, including the International Joint Conference on Artificial Intelligence, Transactions on Knowledge and Data Engineering, IEEE Transactions on Fuzzy Systems, IEEE Transactions on Signal Processing, Information Sciences, Pattern Recognition, Knowledge-Based Systems, Journal of Software and Journal of Automation, where more than 30 SCI journal papers were published as the first author or corresponding author. She is a regular reviewer for multiple IEEE Transactions journals including: IEEE Transactions on Fuzzy Systems (TFS), IEEE Transactions on Knowledge and Data Engineering (TKDE), IEEE Transactions on Computational Social Systems (TCSS), IEEE Transactions on Artificial Intelligence (TAI), and IEEE Transactions on Systems, Man, and Cybernetics: Systems (TSMCS).

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

  1. provincial-level high-level talent in Fujian|Fujian
TQB2440 compared with reference pertuzumab for HER2-positive, ER/PgR-negative, early or locally advanced breast cancer: a multicenter, randomized, double-blind, parallel-controlled, phase III equivalence trial

TQB2440与参比药pertuzumab对比治疗HER2阳性、ER/PgR阴性早期或局部晚期乳腺癌:一项多中心、随机、双盲、平行对照、III期等效性试验

2025-12-150
OAAI
defining cancer initiating cells and their vulnerabilities in renal cell carcinoma

定义肾细胞癌中的癌症起始细胞及其易损性

2025-10-010
OAAI
Molecular mechanism of action and targets of glucocorticoids in lymphoma therapy
2024-03-220
PRE